LabRoots is pleased to announce the 3rd Annual Bioprocessing Virtual Event! Join us for this free, one-day event on April 7, 2021 as we discuss upstream and downstream processing, analytical development and quality, formulation and stability, cell and gene therapy production, and manufacturing.
This year's event includes the following topics:
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2020 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2021 BioProcessing Virtual Event. Submission is free. Submit your abstract here.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits.
Use #LRbioprocessing to follow the conversation!
After completion of a first degree in Chemical Engineering/Biotechnology (FHO Emden, Germany) he carried out a PhD in Applied Molecular Biology at UMIST (Manchester, UK). Following a short postdoctoral period in the Department of Biochemical Engineering at UCL he became a Lecturer and currently holds a position as Associate Professor. He has an established track record in modelling, engineering and scale-up/down of fermentation and cell culture processes. In recognition for his contributions to the development of miniature bioreactor technologies he received the 2010 Pharmaceuticals Division Plenary Award of the AIChE. He has published over 80 papers and co-authored 4 book chapters.
Matt Bochenek received his BS in Industrial and Enterprise Systems Engineering from the University of Illinois Urbana/Champaign. His interest in biological systems made him alter his focus, and he pursued a Ph.D. in Bioengineering at the University of Illinois at Chicago (UIC). Here, he worked with Dr. Jose Oberholzer in a Phase III clinical trial for intraportal islet transplantation. This entails isolating insulin producing islet cells from human donor pancreata and transplanting them intraportally into Type I diabetic patients in order to restore glycemic control. Currently, he works as a senior post-doc in Dr. Dan Anderson and Dr. Bob Langer labs at MIT. and works for cell and. Matt’s work primarily focuses on the development of immunomodulatory biomaterials, specifically for the immuno-protection of islet cells and other cell-based therapies, as well for cancer therapies. Recently, he published in Nature BME to show that anti-fibrotic alginate modified materials can protect islet cells in non-human primates for up to 4 months without the need for immunosuppression.
Mr. Pratik P. Kulkarni is a PhD. Research scholar (awaiting final defense) at the National Forensic Sciences University (NFSU). He received his bachelors in pharmacy from K.B Inst. Of Pharma. Edu. and Research, and a master’s degree in nano drug delivery systems from NFSU, Gandhinagar, India. His research interests include development of drug loaded nanocarriers for combinative drug delivery applications. Till now he has published 9 scientific papers in journals of International repute. His work on Breast cancer nanoformulation was awarded a place in the virtual issue titled “Most original and Most significant scientific contribution” in 2018 (Elsevier).
Sakis Mantalaris is Professor in the W.H. Coulter Department of Biomedical Engineering at Georgia Tech & Emory. Prior, he was Professor of BioSystems Engineering in the Department of Chemical Engineering at Imperial College London. He received his PhD (2000) in Chemical Engineering from the University of Rochester. His expertise is in modelling of biological systems and bioprocesses with a focus on mammalian cell culture systems, stem cell bioprocessing, and tissue engineering. He has published over 170 original manuscripts, co-edited one book, and holds several patents with several more pending. He has received several awards including the Junior Moulton Award for best paper by the Institute of Chemical Engineers (IChemE) in 2004. In 2012, he was elected Fellow of the American Institute for Medical & Biological Engineering and in 2013 he was awarded a European Research Council (ERC) Advanced Award. In 2015, he was awarded the Donald Medal by the Institution of Chemical Engineers (IChemE) for his contributions to biochemical engineering.
Patricia McNeill joined Lundbeck Seattle BioPharmaceuticals Inc. in October 2019 as part of the acquisition of Alder Biopharmaceuticals. As Associate Director of Cell Culture Development, she has overseen the successful upstream process development for early to late stage cell culture and fermentation processes producing therapeutic monoclonal antibodies. She was hired as the 10th employee at Alder and has since held progressive leadership roles including the build-out and expansion of the research development lab for yeast fermentation. As Alder grew and new production platforms were needed, Patricia was tasked in establishing a CHO cell culture platform from the ground up. Prior to Alder, Patricia worked at Corixa Corporation where she was responsible for production of E. coli antigens used in cancer vaccine therapies. Her passion is using Design of Experiment (DOE) studies to decrease Cost of Goods (COGs), increase process efficiency, and robustness, and speed up development timelines.
I am a 5th year PhD candidate in the Bioinformatics & Systems Biology program at UC San Diego with Dr. Nathan Lewis as my advisor. I received a B.S in Biology with a minor in computational neuroscience at Carnegie Mellon University, working on mu-opioid receptor recycling in Dr. Manoj Puthenveedu's lab. I then worked in Dr. Eric Halgren's lab, using ECog data to understand spatiotemporal patterns in sleep and memory. In the Lewis lab, my dissertation examines different points in the lifecycle of biopharmaceuticals, from production to application, using next-generation sequencing technology. My first project-the topic of my talk today- improves the resolution of the transcription start sites (TSSs) in the Chinese Hamster using comprehensive multi-omics across various tissues. This elucidated regulatory regions such as the TATA box and initiator element, enabled CRISPR activation for the Mgat3 gene, and provided a valuable resource for the CHO community. My second focus is on the application of a novel immuno-therapeutic to the clonal makeup of the hematopoietic CD34+ stem and progenitor cell population. Using a recently published single-cell mitochondrial ATAC-seq methodology for lineage tracing, we tracked clonal population expansions and regressions. I am very interested in genetic engineering in combination with sequencing and modeling techniques, and hope to incorporate these techniques to developing and understanding novel therapeutics.
Sandy joined the technical support team at Mirus Bio in 2019 and is responsible for working with scientists on troubleshooting and optimization of their gene delivery experiments and workflows. Before joining Mirus Bio, Sandy completed her doctoral thesis on the topic of regulation of eukaryotic gene expression at the University of Wisconsin-Madison.
Christian Witz has studied chemical process engineering. In his Ph.D. Witz created a novel simulation program for aerated and stirred bioreactors. He was recently named as a fellow in the Spin-Off Fellowship program of the Austrian Research Promotion Agency.
David Wood is a Professor of Chemical and Biomolecular Engineering at The Ohio State University. He received his undergraduate degree from Caltech in 1990 with a double major in Chemical Engineering and Molecular Biology, and then worked on Neupogen® manufacturing at Amgen and downstream process development at Bristol Myers Squibb. Since receiving his PhD from Rensselaer Polytechnic Institute over 20 years ago, professor Wood has developed groundbreaking new technologies in downstream bioprocessing with a focus on self-cleaving affinity tag methods. His work has led to several issued patents in this area, and he is now a co-founder of Protein Capture Science, a startup company commercializing his self-cleaving affinity tag technology.
Astrea Bioseparations Ltd (formerly Prometic Bioseparations Ltd) has long been established as an expert in affinity chromatography and bioseparations. Providing services for ligand design, adsorbent development, large scale adsorbent manufacture (up to 1,000L batch sizes) to GMP ...See more See less
For more than 30 years, GoldBio has been committed to researchers around the world. We know providing quality reagents to scientists leads to discoveries that benefit all. That is why we provide our customers with only the best chemicals, tested in GoldBio labs to ensure the ...See more See less
As a global leader in healthcare, Roche Diagnostics offers a broad portfolio of tools that help healthcare providers in the early detection, prevention, diagnosis and treatment of diseases. In Molecular Diagnostics, we are driven by a vision of working with laboratories like ...See more See less
PENTAPHARM has a long-standing tradition as an innovative and reliable supplier of active ingredients for the pharmaceutical, diagnostic and cosmetic industry. Our roots as researchers, developers and manufacturers of state-of-the-art products reach back to 1948. PENTAPHARM ...See more See less
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Nagarjun is a Scientist in Technical Operations at Sana Biotechnology (Cambridge, MA). He completed his PhD in Medical Sciences at Texas A&M University (Texas), where he worked on development of a universal lentiviral vector platform for different gene therapy applications. After ...See more See less
With more than 10 years of experience, Mark is a passionate expert in the field of biopharmaceutical process development. He worked together with several Top25 Pharma companies in different projects targeting their needs in process development and understanding. Together with his ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events
Research And Development
Labroots Registration (Also interested in)36%
WAVE Newsletter Promotion5%
Trending Newsletter Promotion1%
Social Media Promotions1%
Medical Laboratory Technician8%
Clinical Laboratory Scientist2%
Life Science Company4%
Manufacturer & Biotech/pharma2%
Manufacturer - Other1%